Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BRISTOL MYERS SQUIBB COBMY · Entity 1662 | Director | April 06, 2017 | April 10, 2017 |
| Corteva, Inc.CTVA · Entity 3006 | Director | April 30, 2025 | May 02, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BRISTOL MYERS SQUIBB CO
Report date April 06, 2017 · Filed April 10, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.10 par valueSEC Table I · non-derivative | Direct | 935,571 |
Ending reported balance
After 2017-04-07 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2017-04-06 · Sale · Disposed 17,000 · Balance 952,571 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 22, 2017. F2: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $52.585 to $53.52, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Row 2 · 2017-04-07 · Sale · Disposed 17,000 · Balance 935,571 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 22, 2017. F3: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $52.885 to $53.645, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. |
| Common Stock, $0.10 par valueSEC Table I · non-derivative | Indirect2016 Trust | 200,000 |
Reported balance
Holding disclosure · report date 2017-04-06 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 200,000 |
| Common Stock, $0.10 par valueSEC Table I · non-derivative | Indirect2015 Trust | 41,273 |
Reported balance
Holding disclosure · report date 2017-04-06 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 41,273 |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 22, 2017.
F2: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $52.585 to $53.52, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
F3: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $52.885 to $53.645, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
Corteva, Inc.
Report date April 30, 2025 · Filed May 02, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 37,784.1509 |
Reported balance
After 2025-04-30 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-04-30 · Grant · Acquired 2,990 · Balance 37,784.1509 F1: Includes acquisition of 336.7595 shares pursuant to dividend reinvestment. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes acquisition of 336.7595 shares pursuant to dividend reinvestment.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
DuPont de Nemours, Inc.
Report date September 18, 2017 · Filed June 26, 2019
Section 16 reporting ended · disclosed 2019-06-26. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 18,348 |
Reported balance
After 2017-09-18 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2017-09-18 · Purchase · Acquired 85 · Balance 18,348 F1: The transactions reported in this Form 4 were executed by the reporting person's investment advisor in a managed account as part of the investment advisor's implementation of a large-cap investment strategy. F2: Represents unvested RSUs and direct ownership. |
| Common StockSEC Table I · non-derivative | Direct | 18,631.7889 |
Reported balance
After 2018-03-08 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2018-03-08 · Sale · Disposed 85 · Balance 18,631.7889 F1: The transactions reported in this Form 4 were executed by the reporting person's investment advisor in a managed account as part of the investment advisor's implementation of a large-cap investment strategy. F3: Represents unvested RSUs. |
| Common StockSEC Table I · non-derivative | Direct | 22,231.3904 |
Reported balance
After 2019-05-21 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2019-05-21 · Purchase · Acquired 270 · Balance 22,231.3904 F1: The transactions reported in this Form 4 were executed by the reporting person's investment advisor in a managed account as part of the investment advisor's implementation of a large-cap investment strategy. F2: Represents unvested RSUs and direct ownership. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions reported in this Form 4 were executed by the reporting person's investment advisor in a managed account as part of the investment advisor's implementation of a large-cap investment strategy.
F2: Represents unvested RSUs and direct ownership.
F3: Represents unvested RSUs.
EIDP, Inc.
Report date August 31, 2017 · Filed September 05, 2017
Section 16 reporting ended · disclosed 2017-09-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-08-31 transaction · row 1
1 source rowRow 1 · 2017-08-31 · Disposition to issuer · Disposed 14,242.6413 · Balance 0 F1: Disposed of pursuant to merger agreement between issuer and Dow Chemical Company in exchange for 18,263 shares or stock units, as applicable, of DowDuPont common stock having a market value of $ 67.18 per share, or stock units, as applicable, on the effective date of the merger. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to merger agreement between issuer and Dow Chemical Company in exchange for 18,263 shares or stock units, as applicable, of DowDuPont common stock having a market value of $ 67.18 per share, or stock units, as applicable, on the effective date of the merger.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2010 Filed Mar 4, 2010 23:57 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantPerformance Shares · Derivative | 22,954 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-007209 · doc4.xml · derivative · entry 6 ANDREOTTI LAMBERTO · CIK 0001208099 · Director · Pres, COO & CEO Designate 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,105 Underlying: Common Stock, $0.10 par value · 22,954 shares Expires not disclosed F9 · derivative.exercise_price: Each performance share converts into one share of common stock upon payout in the first quarter of 2010. F10 · shares: Consists of performance shares earned under the 2007-2009 Long-Term Performance Award. F9 · derivative.exercise_date: Each performance share converts into one share of common stock upon payout in the first quarter of 2010. F9 · derivative.expiration_date: Each performance share converts into one share of common stock upon payout in the first quarter of 2010. Read SEC document |
| March 02, 2010 Filed Mar 4, 2010 23:57 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantPerformance Shares · Derivative | 34,986 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-007209 · doc4.xml · derivative · entry 5 ANDREOTTI LAMBERTO · CIK 0001208099 · Director · Pres, COO & CEO Designate 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,151 Underlying: Common Stock, $0.10 par value · 34,986 shares Expires not disclosed F7 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F8 · shares: Consists of performance shares earned under the 2009-2011 Long-Term Performance Award. F7 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F7 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. Read SEC document |
| March 02, 2010 Filed Mar 4, 2010 23:57 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantPerformance Shares · Derivative | 39,278 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-007209 · doc4.xml · derivative · entry 4 ANDREOTTI LAMBERTO · CIK 0001208099 · Director · Pres, COO & CEO Designate 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,165 Underlying: Common Stock, $0.10 par value · 39,278 shares Expires not disclosed F5 · derivative.exercise_price: Each performance share converts into one share of common stock upon payout in the first quarter of 2011. F6 · shares: Consists of performance shares earned under the 2008-2010 Regular Long-Term Performance Award and the 2008-2010 Special Long-Term Performance Award. F5 · derivative.exercise_date: Each performance share converts into one share of common stock upon payout in the first quarter of 2011. F5 · derivative.expiration_date: Each performance share converts into one share of common stock upon payout in the first quarter of 2011. Read SEC document |
| March 02, 2010 Filed Mar 4, 2010 23:57 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantMarket Share Units · Derivative | 65,394 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-007209 · doc4.xml · derivative · entry 3 ANDREOTTI LAMBERTO · CIK 0001208099 · Director · Pres, COO & CEO Designate 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,394 Underlying: Common Stock, $0.10 par value · 65,394 shares Expires not disclosed F3 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock based on the average of the closing share price of the company's common stock on the vesting date and the nine trading days immediately preceding the vesting date. F4 · derivative.exercise_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date and will be converted into shares of common stock based on a conversion factor. F4 · derivative.expiration_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date and will be converted into shares of common stock based on a conversion factor. Read SEC document |
| March 02, 2010 Filed Mar 4, 2010 23:57 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 34,107 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-007209 · doc4.xml · nonDerivative · entry 2 ANDREOTTI LAMBERTO · CIK 0001208099 · Director · Pres, COO & CEO Designate 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,696 F2 · shares: Withheld for the payment of taxes upon payout of shares under a Long-Term Performance Award. Read SEC document |
| March 02, 2010 Filed Mar 4, 2010 23:57 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 72,043 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-007209 · doc4.xml · nonDerivative · entry 1 ANDREOTTI LAMBERTO · CIK 0001208099 · Director · Pres, COO & CEO Designate 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,803 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Consists of shares earned as long-term performance awards under the 2002 Stock Incentive Plan. Read SEC document |
| March 01, 2010 Filed Mar 3, 2010 21:24 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 2,959 | $24.57 | $72,702.63 |
DisclosureSEC source: 0001225208-10-006836 · doc4.xml · nonDerivative · entry 1 ANDREOTTI LAMBERTO · CIK 0001208099 · Director · Pres & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,760 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| December 23, 2009 Filed Dec 28, 2009 18:57 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | SaleCommon Stock, $0.10 par value | 21,558 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-025005 · doc4.xml · nonDerivative · entry 1 ANDREOTTI LAMBERTO · CIK 0001208099 · Director · Pres & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,719 F1 · shares: The reporting person exchanged 21,558 shares of Bristol-Myers Squibb common stock for 13,609 shares of Mead Johnson Nutrition Company common stock in an issuer exchange offer. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| September 21, 2009 Filed Sep 22, 2009 17:53 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 19,726 | $22.52 | $444,229.52 |
DisclosureSEC source: 0001225208-09-019167 · doc4.xml · nonDerivative · entry 1 ANDREOTTI LAMBERTO · CIK 0001208099 · Director · Pres & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,277 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 06, 2009 Filed Mar 10, 2009 22:05 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 4,356 | $18.35 | $79,932.60 |
DisclosureSEC source: 0001225208-09-006764 · doc4.xml · nonDerivative · entry 1 ANDREOTTI LAMBERTO · CIK 0001208099 · Director · Pres & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,307 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 03, 2009 Filed Mar 5, 2009 22:06 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantRestricted Stock Units · Derivative | 31,032 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-006372 · doc4.xml · derivative · entry 2 ANDREOTTI LAMBERTO · CIK 0001208099 · Director · Pres & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,032 Underlying: Common Stock, $0.10 par value · 31,032 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F3 · derivative.exercise_date: One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock. F3 · derivative.expiration_date: One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock. Read SEC document |
| March 03, 2009 Filed Mar 5, 2009 22:06 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantExecutive Option (right to buy) · Derivative | 368,706 | $0.00 Strike: $17.51 | $0.00 |
DisclosureSEC source: 0001225208-09-006372 · doc4.xml · derivative · entry 1 ANDREOTTI LAMBERTO · CIK 0001208099 · Director · Pres & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 368,706 Underlying: Common Stock, $0.10 par value · 368,706 shares Expires 2019-03-02 F1 · derivative.exercise_date: Option is not exercisable until the closing share price of common stock achieves a price of at least 15% above the option grant price and remains at that price for seven consecutive trading days. Option vests 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant, but may not be exercised until the threshold is satisfied. Read SEC document |
| March 02, 2009 Filed Mar 3, 2009 22:16 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 2,841 | $17.74 | $50,399.34 |
DisclosureSEC source: 0001225208-09-005824 · doc4.xml · nonDerivative · entry 2 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243,663 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 01, 2009 Filed Mar 3, 2009 22:16 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 2,959 | $18.41 | $54,475.19 |
DisclosureSEC source: 0001225208-09-005824 · doc4.xml · nonDerivative · entry 1 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,504 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| February 19, 2009 Filed Feb 23, 2009 21:20 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantPerformance Shares · Derivative | 26,709 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-004530 · doc4.xml · derivative · entry 3 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,887 Underlying: Common Stock, $0.10 par value · 26,709 shares Expires not disclosed F5 · derivative.exercise_price: Each performance share is converted into one share of common stock upon distribution in the first quarter of 2010. F6 · shares: Consists of performance shares earned under the 2007-2009 Long-Term Performance Award. F5 · derivative.exercise_date: Each performance share is converted into one share of common stock upon distribution in the first quarter of 2010. F5 · derivative.expiration_date: Each performance share is converted into one share of common stock upon distribution in the first quarter of 2010. Read SEC document |
| February 19, 2009 Filed Feb 23, 2009 21:20 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantPerformance Shares · Derivative | 41,798 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-004530 · doc4.xml · derivative · entry 2 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,178 Underlying: Common Stock, $0.10 par value · 41,798 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share is converted into one share of common stock upon distribution in the first quarter of 2011. F4 · shares: Consists of performance shares earned under the 2008-2010 Regular Long-Term Performance Award and the 2008-2010 Special Long-Term Performance Award. F3 · derivative.exercise_date: Each performance share is converted into one share of common stock upon distribution in the first quarter of 2011. F3 · derivative.expiration_date: Each performance share is converted into one share of common stock upon distribution in the first quarter of 2011. Read SEC document |
| February 19, 2009 Filed Feb 23, 2009 21:20 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantCommon Stock, $0.10 par value | 34,440 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-004530 · doc4.xml · nonDerivative · entry 1 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,463 F1 · shares: Consists of shares earned as long-term performance awards under the 2002 Stock Incentive Plan. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| February 19, 2009 Filed Mar 24, 2009 19:43 UTC Amendment | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 16,304 | $20.51 | $334,395.04 |
DisclosureSEC source: 0001225208-09-007608 · doc4a.xml · nonDerivative · entry 1 ANDREOTTI LAMBERTO · CIK 0001208099 · Director · Pres & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233,159 F1 · kind: This Form 4 is being amended to reflect the shares withheld for taxes upon the distribution of a performance share award. F2 · shares: Shares withheld for payment of taxes upon distribution of long-term performance award. F3 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| September 19, 2008 Filed Sep 23, 2008 20:01 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 19,725 | $21.00 | $414,225.00 |
DisclosureSEC source: 0001225208-08-015043 · doc4.xml · nonDerivative · entry 1 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,023 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| September 10, 2008 Filed Sep 12, 2008 18:30 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 7,891 | $21.67 | $170,997.97 |
DisclosureSEC source: 0001225208-08-014720 · doc4.xml · nonDerivative · entry 1 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,748 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 04, 2008 Filed Mar 6, 2008 22:03 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | GrantRestricted Stock Units · Derivative | 22,358 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-08-000093 · and835.xml · derivative · entry 2 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,358 Underlying: Common Stock, $0.10 par value · 22,358 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F3 · derivative.exercise_date: One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock. F3 · derivative.expiration_date: One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock. Read SEC document |
| March 04, 2008 Filed Mar 6, 2008 22:03 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | GrantExecutive Option (right to buy) · Derivative | 305,909 | $0.00 Strike: $22.14 | $0.00 |
DisclosureSEC source: 0000014272-08-000093 · and835.xml · derivative · entry 1 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,909 Underlying: Common Stock, $0.10 par value · 305,909 shares Expires 2018-03-03 F1 · derivative.exercise_date: Option is not exercisable until the closing share price of common stock achieves a price of at least 15% above the option grant price and remains at that price for seven consecutive trading days. Shares vest 25% per year, on a cumulative basis, commencing one year after the grant date. Read SEC document |
| March 04, 2008 Filed Feb 17, 2009 20:25 UTC Amendment | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantPerformance Shares · Derivative | 22,380 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-09-000007 · primary_doc.xml · derivative · entry 1 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,380 Underlying: Common Stock $0.10 par value · 22,380 shares Expires not disclosed F1 · derivative.exercise_price: (1) Each performance share converts into one share of common stock upon payout in the first quarter of 2010. F1 · derivative.exercise_date: (1) Each performance share converts into one share of common stock upon payout in the first quarter of 2010. F1 · derivative.expiration_date: (1) Each performance share converts into one share of common stock upon payout in the first quarter of 2010. Read SEC document |
| March 02, 2008 Filed Mar 4, 2008 18:35 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 2,841 | $22.61 | $64,235.01 |
DisclosureSEC source: 0000014272-08-000069 · and820.xml · nonDerivative · entry 2 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP BMS & President WW Pharm 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,639 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units. F2 · balance_after: Includes unvested shares of restricted stock and unvested restricted stock units. Read SEC document |
| March 01, 2008 Filed Mar 4, 2008 18:35 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 2,959 | $22.61 | $66,902.99 |
DisclosureSEC source: 0000014272-08-000069 · and820.xml · nonDerivative · entry 1 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP BMS & President WW Pharm 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,480 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock. F2 · balance_after: Includes unvested shares of restricted stock and unvested restricted stock units. Read SEC document |
| September 10, 2007 Filed Sep 12, 2007 20:06 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 9,219 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-07-000175 · and751.xml · nonDerivative · entry 1 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP BMS & President WW Pharm 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,111 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units. F2 · balance_after: Includes unvested restricted stock units. Read SEC document |
| September 10, 2007 Filed Sep 19, 2007 15:48 UTC Amendment | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 7,891 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-07-000182 · and754.xml · nonDerivative · entry 1 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP BMS & President WW Pharm 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,439 F1 · shares: This form is being amended to correct the number of shares withheld for the payment of taxes upon the vesting of resticted stock units. F2 · balance_after: Includes unvested restricted stock units. Read SEC document |
| June 20, 2007 Filed Jun 21, 2007 19:09 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 1,845 | $31.23 | $57,619.35 |
DisclosureSEC source: 0000014272-07-000150 · and736.xml · nonDerivative · entry 1 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP BMS & President WW Pharm 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,330 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| May 08, 2007 Filed May 10, 2007 21:19 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Exercise / conversionOption (right to buy) · Derivative | 30,000 | $0.00 Strike: $28.90 | $0.00 |
DisclosureSEC source: 0000014272-07-000123 · and707.xml · derivative · entry 4 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP BMS & President WW Pharm 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 30,000 shares Expires 2007-06-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Exercisable on the earlier of (i) three years from the date of grant or (ii) the date on which the closing share price achieves $50.00 or above for seven consecutive trading days. Read SEC document |
| May 08, 2007 Filed May 10, 2007 21:19 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 622 | $30.21 | $18,790.62 |
DisclosureSEC source: 0000014272-07-000123 · and707.xml · nonDerivative · entry 3 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP BMS & President WW Pharm 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,175 F3 · shares: Shares withheld for payment of taxes upon exercise of stock option. F1 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| May 08, 2007 Filed May 10, 2007 21:19 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 28,700 | $30.21 | $867,027.00 |
DisclosureSEC source: 0000014272-07-000123 · and707.xml · nonDerivative · entry 2 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP BMS & President WW Pharm 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,797 F2 · shares: Shares withheld for payment of exercise price. F1 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| May 08, 2007 Filed May 10, 2007 21:19 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 30,000 | $28.90 | $867,000.00 |
DisclosureSEC source: 0000014272-07-000123 · and707.xml · nonDerivative · entry 1 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP BMS & President WW Pharm 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,497 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 06, 2007 Filed Mar 8, 2007 22:17 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | GrantRestricted Stock Units · Derivative | 19,800 | $0.00 Strike: $27.01 | $0.00 |
DisclosureSEC source: 0000014272-07-000076 · and678.xml · derivative · entry 4 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP BMS & President WW Pharm 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,800 Underlying: Common Stock, $0.10 par value · 19,800 shares Expires 2017-03-05 F5 · derivative.exercise_date: Consists of restricted stock units with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date. Read SEC document |
| March 06, 2007 Filed Mar 8, 2007 22:17 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | GrantExecutive Option (right to buy) · Derivative | 234,720 | $0.00 Strike: $27.01 | $0.00 |
DisclosureSEC source: 0000014272-07-000076 · and678.xml · derivative · entry 3 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP BMS & President WW Pharm 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,720 Underlying: Common Stock, $0.10 par value · 234,720 shares Expires 2017-03-05 F4 · derivative.exercise_date: Option is not exercisable until the closing share price of common stock achieves a price of at least 15% above the option grant price and remains at that price for seven consecutive trading days. Option vests 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant, but may not be exercised until the threshold is satisfied. Read SEC document |
| March 06, 2007 Filed Mar 8, 2007 22:17 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 2,515 | $27.01 | $67,930.15 |
DisclosureSEC source: 0000014272-07-000076 · and678.xml · nonDerivative · entry 2 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP BMS & President WW Pharm 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,497 F3 · shares: Shares withheld for payment of taxes. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 06, 2007 Filed Mar 8, 2007 22:17 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | GrantCommon Stock, $0.10 par value | 5,261 | $27.01 | $142,099.61 |
DisclosureSEC source: 0000014272-07-000076 · and678.xml · nonDerivative · entry 1 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP BMS & President WW Pharm 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,012 F1 · shares: Consists of shares earned as long-term performance awards under the 2002 Stock Incentive Plan. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 06, 2007 Filed May 10, 2007 21:19 UTC Amendment | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | GrantRestricted Stock Units · Derivative | 19,800 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-07-000122 · and702.xml · derivative · entry 4 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP BMS & President WW Pharm 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,800 Underlying: Common Stock, $0.10 par value · 19,800 shares Expires not disclosed F5 · derivative.exercise_price: This Form 4 is being amended to clarify that each restricted stock unit converts into one share of common stock upon vesting. F6 · derivative.exercise_date: One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock. F6 · derivative.expiration_date: One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock. Read SEC document |
| March 06, 2007 Filed May 10, 2007 21:19 UTC Amendment | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | GrantExecutive Option (right to buy) · Derivative | 234,720 | $0.00 Strike: $27.01 | $0.00 |
DisclosureSEC source: 0000014272-07-000122 · and702.xml · derivative · entry 3 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP BMS & President WW Pharm 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,720 Underlying: Common Stock, $0.10 par value · 234,720 shares Expires 2017-03-05 F4 · derivative.exercise_date: Option is not exercisable until the closing share price of common stock achieves a price of at least 15% above the option grant price and remains at that price for seven consecutive trading days. Option vests 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant, but may not be exercised until the threshold is satisfied. Read SEC document |
| March 06, 2007 Filed May 10, 2007 21:19 UTC Amendment | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 2,515 | $27.01 | $67,930.15 |
DisclosureSEC source: 0000014272-07-000122 · and702.xml · nonDerivative · entry 2 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP BMS & President WW Pharm 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,497 F3 · shares: Shares withheld for payment of taxes. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 06, 2007 Filed May 10, 2007 21:19 UTC Amendment | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | GrantCommon Stock, $0.10 par value | 5,261 | $27.01 | $142,099.61 |
DisclosureSEC source: 0000014272-07-000122 · and702.xml · nonDerivative · entry 1 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP BMS & President WW Pharm 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,012 F1 · shares: Consists of shares earned as long-term performance awards under the 2002 Stock Incentive Plan. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 02, 2007 Filed Mar 6, 2007 19:53 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 2,268 | $26.42 | $59,920.56 |
DisclosureSEC source: 0000014272-07-000058 · and667.xml · nonDerivative · entry 1 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP BMS & President WW Pharm 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,751 F1 · kind: Shares withheld for payment of taxes upon vesting of restricted stock. F2 · balance_after: Includes restricted stock units with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date. Read SEC document |
| December 01, 2006 Filed Dec 4, 2006 19:38 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | GrantExecutive Option (right to buy) · Derivative | 300,000 | $0.00 Strike: $24.74 | $0.00 |
DisclosureSEC source: 0000014272-06-000225 · and626.xml · derivative · entry 1 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP BMS & President WW Pharm 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock, $0.10 par value · 300,000 shares Expires 2016-11-30 F1 · derivative.exercise_date: Option is not exercisable until the closing share price of common stock achieves a price of at least 15% above the option grant price and remains at that price for seven consecutive trading days. Shares vest one-third per year, on a cumulative basis, on the third, fourth, and fifth anniversaries of the grant date. Read SEC document |
| September 08, 2006 Filed Sep 12, 2006 20:38 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 7,634 | $22.96 | $175,276.64 |
DisclosureSEC source: 0000014272-06-000180 · and598.xml · nonDerivative · entry 1 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP BMS & President WW Pharm 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,019 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units. Read SEC document |
| June 30, 2006 Filed Jul 5, 2006 18:41 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 1,326 | $25.77 | $34,171.02 |
DisclosureSEC source: 0000014272-06-000164 · and578.xml · nonDerivative · entry 1 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP BMS & President WW Pharm 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,653 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock. F2 · balance_after: Includes shares of restricted stock with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date. Read SEC document |
| June 20, 2006 Filed Jun 22, 2006 20:50 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 1,260 | $25.48 | $32,104.80 |
DisclosureSEC source: 0000014272-06-000151 · and573.xml · nonDerivative · entry 1 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP BMS & President WW Pharm 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,979 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock. F2 · balance_after: Includes restricted stock units with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date. Read SEC document |
| March 07, 2006 Filed Mar 9, 2006 22:09 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | GrantExecutive Option (right to buy) · Derivative | 115,000 | $0.00 Strike: $22.73 | $0.00 |
DisclosureSEC source: 0000014272-06-000088 · and538.xml · derivative · entry 4 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP BMS & President WW Pharm 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,000 Underlying: Common Stock, $0.10 par value · 115,000 shares Expires 2016-03-06 F4 · derivative.exercise_date: Option is not exercisable until the closing share price of common stock achieves a price of at least 15% above the option grant price and remains at that price for seven consecutive trading days. Option vests 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant, but may not be exercised until the threshold is satisfied. Read SEC document |
| March 07, 2006 Filed Mar 9, 2006 22:09 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 4,486 | $22.73 | $101,966.78 |
DisclosureSEC source: 0000014272-06-000088 · and538.xml · nonDerivative · entry 3 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP BMS & President WW Pharm 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,239 F3 · shares: Shares withheld for payment of taxes. Read SEC document |
| March 07, 2006 Filed Mar 9, 2006 22:09 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | GrantCommon Stock, $0.10 par value | 11,866 | $22.73 | $269,714.18 |
DisclosureSEC source: 0000014272-06-000088 · and538.xml · nonDerivative · entry 2 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP BMS & President WW Pharm 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,725 F2 · shares: Consists of shares earned as long-term performance awards under the 2002 Stock Incentive Plan. Read SEC document |
| March 07, 2006 Filed Mar 9, 2006 22:09 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | GrantCommon Stock, $0.10 par value | 27,600 | $22.73 | $627,348.00 |
DisclosureSEC source: 0000014272-06-000088 · and538.xml · nonDerivative · entry 1 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP BMS & President WW Pharm 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,859 F1 · shares: Shares consist of restricted stock with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date. Read SEC document |
| September 20, 2005 Filed Sep 21, 2005 19:31 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | GrantCommon Stock, $0.10 par value | 125,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-05-000161 · and437.xml · nonDerivative · entry 1 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP BMS & President WW Pharm 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,259 F1 · shares: Shares consist of restricted stock with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date. F2 · balance_after: Includes shares of restricted stock and restricted stock units with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.